For nearly a century, Mayo's Orthopedic Research Division has been involved in advances to alleviate suffering from musculoskeletal disorders. Problems identified in the clinic are taken to the laboratory bench for study, and the results are then translated back into clinical practice.
Currently, 24 funded investigators — many of them active clinicians — have nearly $7 million in annual funding and are doing research in 10 basic research laboratories, performing clinical trials and conducting clinical research in virtually every aspect of musculoskeletal pathology.
Mayo orthopedic investigators hold dozens of patents arising from research done in our laboratories, including ones for new designs of joint replacements, fracture fixation implants and even antibiotic delivery devices that are being used today at Mayo and around the world. Our laboratories also provide opportunities for the education of new researchers.
Today, Mayo's Orthopedic Research Division looks forward to even greater opportunities to improve the well-being of our patients, as advances in molecular medicine, genomics and proteomics allow us to investigate revolutionary new treatments for arthritis, cancer and many sorts of injuries. Your contribution can support Mayo researchers as they pursue these new therapies for orthopedic and musculoskeletal diseases.
Scope of the problem
Musculoskeletal diseases and musculoskeletal trauma affect hundreds of millions of people around the world. In the U.S. alone, musculoskeletal conditions cost society an estimated $254 billion every year, and one out of every seven Americans has a musculoskeletal impairment. The number of people affected by arthritis is expected to reach 60 million within another 10 years. Each year, musculoskeletal conditions result in more than 100 million office visits and 25 million emergency room visits.
Support Orthopedic Research
Philanthropy provides essential support for orthopedic research. Read about how your gift can advance the discovery of musculoskeletal-related treatments.